These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 1833785)
1. The effectiveness of short-term versus long-term exposures to Photofrin II in killing light-activated tumor cells. Chapman JD; Stobbe CC; Arnfield MR; Santus R; McPhee MS Radiat Res; 1991 Oct; 128(1):82-9. PubMed ID: 1833785 [TBL] [Abstract][Full Text] [Related]
2. Oxygen dependency of tumor cell killing in vitro by light-activated Photofrin II. Chapman JD; Stobbe CC; Arnfield MR; Santus R; Lee J; McPhee MS Radiat Res; 1991 Apr; 126(1):73-9. PubMed ID: 1826959 [TBL] [Abstract][Full Text] [Related]
3. Protection against light-activated photofrin II killing of tumor cells by nitroimidazoles. Santus R; Stobbe CC; McPhee MS; Chapman JD Radiat Res; 1992 Apr; 130(1):31-7. PubMed ID: 1532856 [TBL] [Abstract][Full Text] [Related]
4. Photosensitizing effects of hematoporphyrin derivative and photofrin II on the plasma membrane enzymes 5'-nucleotidase, Na+K+-ATPase, and Mg2+-ATPase in R3230AC mammary adenocarcinomas. Gibson SL; Murant RS; Hilf R Cancer Res; 1988 Jun; 48(12):3360-6. PubMed ID: 2836053 [TBL] [Abstract][Full Text] [Related]
5. The effect of photodynamic therapy on a retinoblastoma-like tumour. An experimental in vitro and in vivo study on the potential use of photodynamic therapy in the treatment of retinoblastoma. Winther JB Acta Ophthalmol Suppl (1985); 1990; (197):1-37. PubMed ID: 2176429 [TBL] [Abstract][Full Text] [Related]
6. Phototoxicity, redox behavior, and pharmacokinetics of benzophenoxazine analogues in EMT-6 murine sarcoma cells. Cincotta L; Foley JW; Cincotta AH Cancer Res; 1993 Jun; 53(11):2571-80. PubMed ID: 8495421 [TBL] [Abstract][Full Text] [Related]
7. Photosensitizing effects of Photofrin II on the site-selected mitochondrial enzymes adenylate kinase and monoamine oxidase. Murant RS; Gibson SL; Hilf R Cancer Res; 1987 Aug; 47(16):4323-8. PubMed ID: 3038310 [TBL] [Abstract][Full Text] [Related]
8. Sensitivity of different human lung cancer histologies to photodynamic therapy. Perry RR; Matthews W; Mitchell JB; Russo A; Evans S; Pass HI Cancer Res; 1990 Jul; 50(14):4272-6. PubMed ID: 2142015 [TBL] [Abstract][Full Text] [Related]
9. Comparison of fluorescence and photodynamic activities of whole hematoporphyrin derivative and its enriched active components. Nelson JS; Wright WH; Berns MW J Natl Cancer Inst; 1985 Dec; 75(6):1135-40. PubMed ID: 2933546 [TBL] [Abstract][Full Text] [Related]
10. Tolyporphin: a natural product from cyanobacteria with potent photosensitizing activity against tumor cells in vitro and in vivo. Morlière P; Mazière JC; Santus R; Smith CD; Prinsep MR; Stobbe CC; Fenning MC; Golberg JL; Chapman JD Cancer Res; 1998 Aug; 58(16):3571-8. PubMed ID: 9721863 [TBL] [Abstract][Full Text] [Related]
11. Effect of photofrin II and light energy on retinoblastoma-like cells in vitro. Dose-response relationships, effect of light dose rate and recovery ratio. Winther J J Cancer Res Clin Oncol; 1989; 115(1):73-8. PubMed ID: 2522095 [TBL] [Abstract][Full Text] [Related]
12. In vitro photodynamic therapy of human lung cancer: investigation of dose-rate effects. Matthews W; Cook J; Mitchell JB; Perry RR; Evans S; Pass HI Cancer Res; 1989 Apr; 49(7):1718-21. PubMed ID: 2522346 [TBL] [Abstract][Full Text] [Related]
13. In vitro photodynamic treatment of normal and human papilloma virus-transfected keratinocytes with photofrin II and red light. Bernstein EF; Glass JM; DeGraff WG; Schlegel R; Black C; Fisher JM; Cook SN; Glatstein E; Russo A; Mitchell JB Arch Dermatol; 1991 May; 127(5):683-7. PubMed ID: 1850973 [TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy of murine skin tumors using Photofrin-II. Mukhtar H; Agarwal R; Athar M; Lewen RL; Elmets CA; Bickers DR Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):169-75. PubMed ID: 1839955 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo photosensitizing applications of Photofrin in malignant melanoma cells. Chang CJ; Yu JS; Wei FC Chang Gung Med J; 2008; 31(3):260-7. PubMed ID: 18782948 [TBL] [Abstract][Full Text] [Related]
16. Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro. Dysart JS; Patterson MS Phys Med Biol; 2005 Jun; 50(11):2597-616. PubMed ID: 15901957 [TBL] [Abstract][Full Text] [Related]
17. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow. Chan WS; Brasseur N; La Madeleine C; van Lier JE Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717 [TBL] [Abstract][Full Text] [Related]
18. Short- and long-term normal tissue damage with photodynamic therapy in pig trachea: a fluence-response pilot study comparing Photofrin and mTHPC. Murrer LH; Hebeda KM; Marijnissen JP; Star WM Br J Cancer; 1999 May; 80(5-6):744-55. PubMed ID: 10360652 [TBL] [Abstract][Full Text] [Related]
19. Interdependence of drug dose, incubation time & light dose on hematoporphyrin derivative induced photoinactivation of brain tumour cells. Gangola P; Joshi NB Indian J Med Res; 1990 Dec; 92():467-70. PubMed ID: 2150403 [TBL] [Abstract][Full Text] [Related]
20. Subcellular localization of Photofrin determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: when plasma membranes are the main targets. Hsieh YJ; Wu CC; Chang CJ; Yu JS J Cell Physiol; 2003 Mar; 194(3):363-75. PubMed ID: 12548556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]